PHARMA-TEAM AS
1397 NESØYA
Return on Equity
77,15Â %
Current Ratio
5,39
Debt-to-Equity Ratio
0
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 1Â 162Â 000 | |
| Net Income | 871Â 000 | |
| Total Assets | 1Â 386Â 000 | |
| Total Equity | 1Â 129Â 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 1Â 162Â 000 | |
| Expenditure | 45Â 000 | |
| Operating Profit | 1Â 117Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 0 | |
| Financial Balance | 0 | |
| Earnings Before Tax | 1Â 117Â 000 | |
| Tax | 246Â 000 | |
| Net Income | 871Â 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 0 | |
| Total Current Assets | 1Â 386Â 000 | |
| Total Assets | 1Â 386Â 000 | |
| Total Retained Equity | 1Â 105Â 000 | |
| Total Equity | 1Â 129Â 000 | |
| Total Long-Term Debt | 0 | |
| Total Current Debt | 257Â 000 | |
| Total Equity and Debt | 1Â 386Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 1Â 162Â 000 | |
| Other Income | 0 | |
| Revenue | 1Â 162Â 000 | |
| Cost of Goods Sold | 19Â 000 | |
| Salary Costs | 0 | |
| Depreciation | 0 | |
| Impairment | 0 | |
| Expenditure | 45Â 000 | |
| Operating Profit | 1Â 117Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 0 | |
| Financial Balance | 0 | |
| Dividends | 0 | |
| Net Income | 871Â 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 0 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 0 | |
| Total Fixed Assets | 0 | |
| Stock | 0 | |
| Total Investments | 0 | |
| Cash, Bank | 1Â 319Â 000 | |
| Total Current Assets | 1Â 386Â 000 | |
| Total Assets | 1Â 386Â 000 | |
| Total Equity | 1Â 129Â 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 0 | |
| Creditors | 0 | |
| Unpaid Taxes | 7Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 4Â 000 | |
| Total Current Debt | 257Â 000 | |
| Total Equity and Debt | 1Â 386Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 77,15Â % | |
| Debt-to-Equity Ratio | 0 | |
| Operating Profit Margin | 96,13Â % | |
| Current Ratio | 5,39 | |
| Quick Ratio | 5,39 | |
| Equity Ratio | 0,81 | |
| Gross Profit Margin | 98,36Â % |
Rotate your device to see the full table